Cargando…
Cancer Therapeutic Targeting of Hypoxia Induced Carbonic Anhydrase IX: From Bench to Bedside
SIMPLE SUMMARY: Tumor hypoxia remains a significant problem in the effective treatment of most cancers. Tumor cells within hypoxic niches tend to be largely resistant to most therapeutic modalities, and adaptation of the cells within the hypoxic microenvironment imparts the cells with aggressive, in...
Autores principales: | McDonald, Paul C., Chafe, Shawn C., Supuran, Claudiu T., Dedhar, Shoukat |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9322110/ https://www.ncbi.nlm.nih.gov/pubmed/35884358 http://dx.doi.org/10.3390/cancers14143297 |
Ejemplares similares
-
Recent Developments in Targeting Carbonic Anhydrase IX for Cancer Therapeutics
por: McDonald, Paul C., et al.
Publicado: (2012) -
Carving out its niche: A role for carbonic anhydrase IX in pre-metastatic niche development
por: Chafe, Shawn C, et al.
Publicado: (2015) -
Coordinated Regulation of Metabolic Transporters and Migration/Invasion by Carbonic Anhydrase IX
por: McDonald, Paul C., et al.
Publicado: (2018) -
A Carbonic Anhydrase IX/SLC1A5 Axis Regulates Glutamine Metabolism Dependent Ferroptosis in Hypoxic Tumor Cells
por: Venkateswaran, Geetha, et al.
Publicado: (2023) -
A Phase 1 Study of SLC-0111, a Novel Inhibitor of Carbonic Anhydrase IX, in Patients With Advanced Solid Tumors
por: McDonald, Paul C., et al.
Publicado: (2020)